The global sleep apnea diagnostics market was valued at $99million in 2017, and is expected to reach $168 million by 2025, registering a CAGR of 6.8% from 2018 to 2025

Friday, January 11, 2019 General News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, Jan. 10, 2019 /PRNewswire/ -- Sleep Apnea Diagnostics Market by Product (Polysomnography (PSG) Device, Actigraphy System, Respiratory Polygraph, Sleep Apnea Screening Device, and Oximeter) and End User (Hospitals & Sleep Laboratories and Home Care Settings): Global Opportunity Analysis and Industry Forecast, 2018 - 2025

Read the full report: https://www.reportlinker.com/p05698761 Sleep Apnea Diagnostics Market Overview: The global sleep apnea diagnostics market was valued at $99million in 2017, and is expected to
reach $168 million by 2025, registering a CAGR of 6.8% from 2018 to 2025. Sleep apnea is a sleep disorder that fluctuates with the patient's breathing pattern. It may decrease or even stop patient's breathing completely during sleep. In few cases, it may pause the breathing (called apnea), which can last 10 seconds or longer and can occur 30 times or more in an hour. Symptoms of sleep apnea include daytime sleepiness, loud snoring, and restless sleep. Approximately 18 million Americans suffer from sleep apnea, while only 20% have been diagnosed and treated. The major key factors that drive the growth of the sleep apnea diagnostics market include rise in sedentary lifestyle diseases such as diabetes & others and surge in geriatric population. Obesity is considered one of the major risk factor for the development and progression of sleep apnea. In addition, technological advancements to make products more comfortable for patients and considerable upsurge in sleep apnea disorders boost the growth of the global market. However, high cost associated with these devices, limited reimbursement of these devices, and low patient awareness regarding sleep apnea are projected to hinder the market growth. Moreover, increase in preference for home healthcare devices among patients is projected to create lucrative growth opportunities in the near future. The global sleep apnea diagnostics market is segmented based on product and region. Based on product, the market is divided into polysomnography (PSG) device, actigraphy system, respiratory polygraph, sleep apnea screening device, and oximeter. Based on end user, the market is bifurcated into hospitals & sleep laboratories and home care settings. By region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA. Key Benefits for Sleep Apnea Diagnostics Market: The study provides an in-depth analysis of the global sleep apnea diagnostics market along with the current trends and future estimations to elucidate the imminent investment pockets. A comprehensive analysis of the factors that drive and restrict the market growth is provided. A comprehensive quantitative analysis of the industry is provided from 2018 to 2025 to assist stakeholders to capitalize on the prevailing market opportunities. An extensive analysis of the key segments of the industry helps understand the global trends in the sleep apnea diagnostics market. Key players and their strategies are provided to understand the competitive outlook of the industry. Sleep Apnea Diagnostics Key Market Segments: By ProductPolysomnography Device (PSG) Clinical PSG Device Ambulatory PSG Device Sleep Apnea Screening Device Actigraphy Monitoring Device Respiratory Polygraph Oximeter Finger Tip Oximeter Handheld Oximeter Wrist-worn Oximeter Tabletop Oximeter Others By End UserHospitals & Sleep Laboratories Home Care Settings By RegionNorth America U.S. Canada Mexico Europe UK France Germany Italy Spain Rest of Europe Asia-Pacific Japan China India Australia Rest of Asia-Pacific LAMEA Saudi Arabia South Africa Brazil Rest of LAMEA KEY MARKET PLAYERS Cadwell Laboratories Inc. DeVilbiss Healthcare LLC. Koninklijke Philips N.V Medtronic plc Mindray Natus Medical Incorporated Nihon Kohden Corporation Resmed Smiths Medical SomnoMedics The other players in the value chain include (profiles not included in the report): Cleveland Medical Devices, Inc. Compumedics Ltd. Fisher & Paykel Healthcare Limited Vyaire Medical, Inc Becton, Dickinson and Company BMC Medical Co., LtdRead the full report: https://www.reportlinker.com/p05698761 About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ Contact Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001

Cision View original content:http://www.prnewswire.com/news-releases/the-global-sleep-apnea-diagnostics-market-was-valued-at-99million-in-2017--and-is-expected-to-reach-168-million-by-2025--registering-a-cagr-of-6-8-from-2018-to-2025--300776394.html

SOURCE Reportlinker



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store